...
首页> 外文期刊>Biochimica et biophysica acta. Biomembranes >Characterization of 3-methoxy flavones for their interaction with ABCG2 as suggested by ATPase activity
【24h】

Characterization of 3-methoxy flavones for their interaction with ABCG2 as suggested by ATPase activity

机译:ATPase活性表明3-甲氧基黄酮与ABCG2相互作用的特征

获取原文
获取原文并翻译 | 示例

摘要

Breast Cancer Resistance Protein (BCRP/ABCG2) belongs to the superfamily of ATP binding cassette (ABC) transporters. Characteristic of some of these transporter proteins is the transport of a variety of structurally unrelated substances against a concentration gradient by using the energy of ATP hydrolysis. ABCG2 has been found to confer multidrug resistance (MDR) in cancer cells. Several anticancer drugs have been identified as ABCG2 substrates including mitoxantrone, etoposide and topotecan. As inhibition of the transporter is one of the strategies to overcome MDR, we have synthesized and tested several 3-methoxy flavones and investigated them for their ABCG2 inhibition. Among these, pentamethyl quercetin (compound . 4) and pentamethyl morin (compound . 5) were found to be fluorescent and hence screened for their possible transport by ABCG2 using confocal microscopy. This study showed that pentamethyl quercetin was far less accumulated in ABCG2 overexpressing MDCK BCRP cells as compared to MDCK sensitive cells, suggesting possible efflux of this compound by ABCG2. Pentamethyl morin showed no visible difference in both cell lines. Based on this observation, we studied several other fluorescent 3-methoxy flavones for their accumulation in ABCG2 overexpressing cells. To confirm the substrate or inhibitor nature of the tested compounds, these compounds were further investigated by ATPase assay. If stimulation of the transporter ATPase activity is detected, one can conclude that the compound is probably a transported substrate. All compounds except pentamethyl morin (compound . 5) and tetramethyl quercetin (compound . 6) were found to stimulate ATPase activity pointing to possible substrates despite being potent inhibitors of ABCG2.
机译:乳腺癌抗性蛋白(BCRP / ABCG2)属于ATP结合盒(ABC)转运蛋白的超家族。其中一些转运蛋白的特征是利用ATP水解能,针对浓度梯度转运了各种结构无关的物质。已发现ABCG2赋予癌细胞多药耐药性(MDR)。几种抗癌药物已被鉴定为ABCG2底物,包括米托蒽醌,依托泊苷和托泊替康。由于抑制转运蛋白是克服MDR的策略之一,因此我们合成并测试了几种3-甲氧基黄酮,并研究了它们对ABCG2的抑制作用。其中,发现五甲基槲皮素(化合物4)和五甲基香豆素(化合物5)是荧光的,因此使用共聚焦显微镜对ABCG2可能的转运进行了筛选。这项研究表明,与MDCK敏感细胞相比,在过表达ABCG2的MDCK BCRP细胞中积累的五甲基槲皮素要少得多,这表明该化合物可能由ABCG2流出。五甲基香豆素在两种细胞系中均无可见差异。基于此观察,我们研究了其他几种荧光3-甲氧基黄酮在ABCG2过表达细胞中的积累。为了确认所测试化合物的底物或抑制剂性质,通过ATPase测定进一步研究了这些化合物。如果检测到转运蛋白ATP酶活性的刺激,则可以得出结论该化合物可能是被转运的底物。尽管是有效的ABCG2抑制剂,但发现五甲基香豆素(化合物5)和四甲基槲皮素(化合物6)以外的所有化合物均能刺激ATPase活性,从而指向可能的底物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号